Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ILMN > SEC Filings for ILMN > Form 8-K on 16-Nov-2012All Recent SEC Filings

Show all filings for ILLUMINA INC



Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure

On November 16, 2012, Illumina, Inc. confirmed that it is "Party H" as named in the Schedule 14D-9 (and related amendments) filed by Complete Genomics, Inc. in connection with the tender offer by Beta Acquisition Corporation, a Delaware corporation ("Purchaser") and a wholly owned subsidiary of BGI-Shenzhen, a company organized under the laws of the People's Republic of China (together with Purchaser, "BGI"), to purchase all of the outstanding common stock of Complete Genomics. Illumina further confirmed that it submitted proposals to acquire Complete Genomics on the terms disclosed by Complete Genomics in its Schedule 14D-9 (and related amendments). Illumina's most recent proposal, submitted on November 5, 2012, included the following terms:

a per share cash purchase price of $3.30, which represented approximately a 5% premium over the consideration offered by BGI;

financed with cash-on-hand; and

without any condition for further due diligence.

  Add ILMN to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ILMN - All Recent SEC Filings
Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.